Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

158
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
158
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

59
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
59
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

266
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
266
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

151
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
151
Management of Insomnia01:19

Management of Insomnia

274
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
274
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

196
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
196

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of Vagus Nerve Stimulation on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report.

The Journal of clinical psychiatry·2026
Same author

A Mixed Methods Study for Human Factors Science and Ergonomics Education in Vascular Surgery Training.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Increased aperiodic exponents track depressive symptom severity in refractory epilepsy.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026
Same author

Correcting diffusion artifacts in urinary oxygen tension monitoring.

Scientific reports·2026
Same author

Network Pharmacology and Molecular Docking-Based Investigation of Empagliflozin's Therapeutic Potential in Chronic Kidney Disease.

Life (Basel, Switzerland)·2026
Same author

A multi-view pipeline and benchmark dataset for 3D hand pose estimation in surgery.

International journal of computer assisted radiology and surgery·2026

相关实验视频

Updated: Jul 15, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K

普罗波治疗耐药性抑郁症:一个随机对照试验.

Scott C Tadler, Keith G Jones, Carter Lybbert

    medRxiv : the preprint server for health sciences
    |September 25, 2023
    PubMed
    概括

    在一项小型试验中,高剂量的普罗波显示出潜在的抗抑郁作用,这表明对治疗耐药抑郁症的剂量依赖的益处. 需要进一步研究更大的样本大小来证实这些发现.

    更多相关视频

    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
    07:12

    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

    Published on: August 2, 2021

    3.6K
    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
    04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    28.6K

    相关实验视频

    Last Updated: Jul 15, 2025

    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
    08:20

    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

    Published on: August 11, 2015

    14.0K
    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
    07:12

    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

    Published on: August 2, 2021

    3.6K
    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
    04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    28.6K

    科学领域:

    • 神经科学是一个神经科学.
    • 精神病学是一个精神病学.
    • 麻醉学 麻醉学

    背景情况:

    • 像胺和氧化这样的麻醉剂已经证明了抗抑郁药的特性.
    • 之前的开放试验表明,在高剂量时,可提供强大的抗抑郁作用,诱导电脑电图 (EEG) 突发抑制.
    • 这项研究在一项随机对照试验中研究了普罗波的剂量依赖性抗抑郁药效应.

    研究的目的:

    • 为了比较抗抑郁药高剂量与低剂量普罗波在治疗耐药抑郁症患者中的抗抑郁疗效.
    • 为了评估由propofol诱导的EEG爆发抑制对抗抑郁药物结果的影响.
    • 评估二次结果,包括自杀念头,焦虑,功能障碍和生活质量.

    主要方法:

    • 一项随机对照试验 (NCT03684447),涉及24名患有中度至重度,耐治疗抑郁症的参与者.
    • 参与者接受了一系列6项治疗,随机分配给低剂量或高剂量醇.
    • 输液是通过实时处理的正面EEG引导的,以实现特定的药理动力学目标,主要结果是汉密尔顿抑郁评分表 (HDRS-24) 和患者健康问卷 (PHQ-9).

    主要成果:

    • 低剂量和高剂量普罗波都被很好地容忍,具有有效的失明作用.
    • 高剂量组的HDRS-24得分平均下降幅度较大 (-9.3) 与低剂量组相比 (-5.3),尽管差异在统计学上并不显著 (p=0.24).
    • 同样,PHQ-9分数显示,高剂量组 (-4.8) 与低剂量组 (-2.0) 的减少更大,接近统计学意义 (p=0.09).

    结论:

    • 观察到的中等效应表明,醇具有潜在的剂量依赖的抗抑郁药物特性.
    • 研究结果表明,更高的剂量,可能是诱导突发抑制的剂量,可能会产生更大的抗抑郁药效益.
    • 建议进行更多治疗的更大规模试验,以确认剂量依赖性,并探索潜在的抗抑郁药机制.